Drug discovery and development – Page 36
-
BusinessService with a smile
Company profile: Charnwood Molecular is more than a run-of-the-mill contract synthesis provider
-
FeatureAnimal pharm
Making drugs to treat animals is potentially lucrative – but also difficult, as Clare Sansom discovers
-
News
Former student sues Harvard for $10 million
PhD chemist seeks damages in row over patent royalties
-
OpinionTarget acquired
Knowing a drug’s exact biochemistry has never been a prerequisite for approval, says Derek Lowe, and nor should it be
-
Business
Data-sharing partnership for drug discovery
Collaborative project aims to assist medicinal chemistry efforts
-
OpinionCompulsory licences: necessity or threat?
Are compulsory licences for patent-protected drugs a necessary measure, or a threat to innovation?
-
NewsAntibiotic resistance is a ‘ticking time bomb’
Efforts to tackle the threat will need new thinking, but their may be no easy solutions or short cuts to new drugs
-
Opinion
New antibiotics: what's the hold up?
It’s more a research problem, than a commercial one, says Derek Lowe
-
NewsPharmaSea to scour ocean depths for new drugs
Bioprospecting project will investigate marine organisms in the search for new antibiotics and central nervous system therapies
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
FeatureMaking pain history
From ancient folk remedy to the wonder drug of the early industrial age and beyond. Mike Sutton traces the remarkable history of aspirin
-
Business
Return on drug R&D dropping
The pharma industry is getting less and less return on investment in R&D but trend seems to be bottoming out
-
Business
Drug R&D costs rising
Review from UK consultancy suggests ten-fold increase in per medicine R&D costs over last 30 years
-
CareersNobel signals for new drugs
Sarah Houlton talks to a company that’s capitalising on the chemistry of communication
-
Business
Bayer and Evotec team up on endometriosis
German collaboration aims to develop three drug candidates in five years
-
NewsChinese drug makers accused of using ‘gutter oil’
Oil reclaimed from drains may have been used to make an antibiotic intermediate
-
FeatureFood with a function
Compounds normally thought of as medicines are being added to food. Elinor Hughes looks at the scientific and regulatory challenges facing these nutraceuticals.
-
OpinionProtecting patients at all costs
Suffering stagnant output, and beset by patent expiries and spiralling costs, drug discovery is in poor health. Simon Campbell prescribes a remedy
-
OpinionMonopoly money
Dean Baker says it’s time to start talking seriously about the way in which pharma is funded